YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
(RTTNews) - Intelligent Bio Solutions Inc. (INBS), a medical technology company, on Tuesday announced initiation of a clinical study to support a 510(k) clearance from the U.S. Food and Drug Administration (FDA) its Fingerprint Drug Screen…
* Intelligent Bio Solutions press release [https://seekingalpha.com/pr/20513272-intelligent-bio-solutions-reports-fiscal-third-quarter-revenue-growth-of-46-percent-year-over] (INBS [https://seekingalpha.com/symbol/INBS]): Q3 GAAP EPS of -$…
Successful delivery in partnership with Syrma Johari validates manufacturing scale, strengthens commercial readiness, and supports planned U.S. market entry in 2026 Partnership on track to deliver annual production cost savings of more tha…
(RTTNews) - Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates. Zentalis Pha…
NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of…
Intelligent Bio Solutions (INBS) reported late Wednesday an agreement with two healthcare-focused in PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Intelligent Bio Solutions INBS recently announced a new strategic manufacturing partnership aimed at strengthening its global production capabilities and improving long-term profitability. The collaboration supports the company’s efforts t…
Intelligent Bio Solutions (INBS) has entered a partnership with Syrma Johari to expand the production of its intelligent fingerprint drug screening reader. The partnership is anticipated to generate financial and operational benefits for I…
* Intelligent Bio Solutions (INBS [https://seekingalpha.com/symbol/INBS]) has entered into a securities purchase agreement with two healthcare focused institutional investors to issue, in a private placement of 2.30M shares of common stock…
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it entere…
(RTTNews) - Shares of Intelligent Bio Solutions Inc. (INBS) more than doubled today after the medical technology company announced a strategic manufacturing partnership with Syrma Johari MedTech Ltd for its flagship Intelligent Fingerprint…
Intelligent Bio Solutions, Inc. NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, non-invas…
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its manag…
Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year-over-year, driven by consumable cartridge sales and customer base expansion Gross profit margins increased 690 basis points year-over-year to 46.6%, re…
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition o…
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio S…
* Intelligent Bio Solutions reports record monthly cartridge sales for July. * Shipped 519 boxes, representing around 12500 cartridges, and a 60% year-on-year. * A recent significant tender win has secured a multi-site, high-volume contrac…
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its highest-ev…
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and T…
* Intelligent Bio Solutions press release [https://seekingalpha.com/pr/20202508-intelligent-bio-solutions-reports-fiscal-2025-fourth-quarter-and-full-year-results] (NASDAQ:INBS [https://seekingalpha.com/symbol/INBS]): FY GAAP EPS of -$2.00…
Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increase…
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing and screening solutions, today announced…
* Intelligent Bio Solutions (NASDAQ:INBS [https://seekingalpha.com/symbol/INBS]) announced [https://seekingalpha.com/pr/20193193-intelligent-bio-solutions-announces-preliminary-fiscal-fourth-quarter-revenue-with-double] on Thursday prelimi…
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through…
Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday. Intelligent Bio Solutions is a medical technology company delivering intelligent, rapi…
NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the submission…
* Intelligent Bio Solutions (NASDAQ:INBS [https://seekingalpha.com/symbol/INBS]) said on Wednesday that it has secured a major contract [https://seekingalpha.com/pr/20182742-intelligent-bio-solutions-secures-major-drug-testing-tender-with-…
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secured…
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced an agreement b…
Data confirms Company’s ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" o…
NEW YORK - Intelligent Bio Solutions Inc. (Nasdaq:INBS) announced Wednesday a new global distribution agreement with Texas-based SMARTOX to distribute its SmarTest Patch drug detection product in international markets outside the United St…
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global d…
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition o…
Intelligent Bio Solutions Inc. (NASDAQ:INBS), a micro-cap company with a market capitalization of $12.65 million, announced amendments to the employment agreements of its President and Chief Executive Officer, Harry Simeondis, and Chief Fi…
NEW YORK - Intelligent Bio Solutions Inc. (NASDAQ:INBS), a micro-cap healthcare technology company with a market value of $12.3 million, is expanding its fingerprint-based drug screening technology across Scandinavia through its partnershi…
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success of…